drugset / Trial / NCT04329442
Accelerated PrEP Access for Black MSM and TW
NaSingle-groupOpen-labelPrevention
Summary
The investigators will pilot-test an accelerated PrEP initiation approach among young high-risk Black/African American (B/AA) men who have sex with men (MSM) and transgender women (YMSM/TW) at the point of care in community contexts.
Timeline
- Start
- 2020-04-01
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
Outcome
Outcome not reported
Stopped (Enrollment): “COVID-19 caused substantial barriers to recruitment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emtricitabine / Tenofovir Disoproxil | Unknown | 200 mg | Oral |